
|Articles|November 15, 2004
Conflict-of-interest rules stiffen for CME activity
Are ophthalmologists and other physicians who have financial relationships with pharmaceutical companies incapable of unbiased work in CME activity? Or, are those who believe any physician-regardless of income sources-can have unfettered, impartial teaching phi-losophies just kidding themselves as to the reality of the medical market place?
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Dr. Mali’s top 5 predictions in ophthalmology for 2026
2
FDA clears Novaliq’s Investigational New Drug application for NOV05
3
Low-dose pilocarpine shrinks pupil without altering accommodation in presbyopia
4
Eye exams could enable earlier detection of systemic disease
5



























